Literature DB >> 33496821

Do Black and Asian individuals wait longer for treatment? A survival analysis investigating the effect of ethnicity on time-to-clinic and time-to-treatment for diabetic eye disease.

Varo Kirthi1,2, Kate I Reed3, Ramith Gunawardena4, Komeil Alattar4, Catey Bunce4, Timothy L Jackson4,3.   

Abstract

AIMS/HYPOTHESIS: This study explored the impact of ethnicity on time-to-clinic, time-to-treatment and rates of vision loss in people referred to hospital with diabetic eye disease.
METHODS: A survival analysis was performed on all referrals from an inner-city diabetic eye screening programme to a tertiary hospital eye service between 1 October 2013 and 31 December 2017. Exclusion criteria were failure to attend hospital, distance visual acuity in both eyes too low to quantify with the Early Treatment Diabetic Retinopathy Study (ETDRS) letter chart and treatment received prior to referral. Demographic and screening grade data were collected at the point of referral. Small-area statistics and census data were used to calculate indices of multiple deprivation. The main outcome measures were time taken from the date of referral for an individual to achieve the following: (1) attend the first hospital clinic appointment; (2) receive the first macular laser, intravitreal anti-vascular endothelial growth factor injection or pan-retinal photocoagulation treatment, in either eye; and (3) lose at least ten ETDRS letters of distance visual acuity, in either eye.
RESULTS: Of 2062 referrals, 1676 individuals were included. Mean age (± SD) was 57.6 ± 14.7 years, with 52% male sex and 86% with type 2 diabetes. The ethnicity profile was 52% Black, 30% White, 10% Asian and 9% mixed/other, with similar disease severity at the time of referral. Time-to-clinic was significantly longer for Asian people than for Black people (p = 0.03) or White people (p = 0.001). Time-to-treatment was significantly longer for Black people than for White people (p = 0.02). Social deprivation did not significantly influence time-to-treatment. There were no significant differences in the rates of vision loss between ethnic groups. CONCLUSIONS/
INTERPRETATION: Black people wait longer for hospital eye treatment compared with their White counterparts. The reasons for this delay in treatment warrant further investigation.

Entities:  

Keywords:  Clinical diabetes; Healthcare delivery; Retinopathy; Socioeconomic aspects

Mesh:

Year:  2021        PMID: 33496821      PMCID: PMC7940160          DOI: 10.1007/s00125-020-05364-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  31 in total

1.  The effect of race on the referral process for invasive cardiac procedures.

Authors:  L C Einbinder; K A Schulman
Journal:  Med Care Res Rev       Date:  2000       Impact factor: 3.929

2.  Treatment compliance and adherence among patients with diabetic retinopathy and age-related macular degeneration treated by anti-vascular endothelial growth factor under universal health coverage.

Authors:  Reinhard Angermann; Teresa Rauchegger; Yvonne Nowosielski; Marina Casazza; Angelika Bilgeri; Hanno Ulmer; Claus Zehetner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-09       Impact factor: 3.117

3.  Loss to Follow-up After Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Patients with Diabetic Macular Edema.

Authors:  Xinxiao Gao; Anthony Obeid; Christopher M Aderman; Katherine E Talcott; Ferhina S Ali; Murtaza K Adam; Barry W Rovner; Leslie Hyman; Allen C Ho; Jason Hsu
Journal:  Ophthalmol Retina       Date:  2018-11-10

4.  The Test-Retest Variability of the COMPlog System in Participants with Induced Non-Normal Visual Acuity.

Authors:  Mun Wei Kan; Anne Bjerre
Journal:  Br Ir Orthopt J       Date:  2019-04-11

5.  Ranibizumab for exudative age-related macular degeneration: A five year study of adherence to follow-up in a real-life setting.

Authors:  E Boulanger-Scemama; G Querques; F About; N Puche; M Srour; V Mane; N Massamba; F Canoui-Poitrine; E H Souied
Journal:  J Fr Ophtalmol       Date:  2015-04-23       Impact factor: 0.818

6.  Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study.

Authors:  M I Harris; R Klein; C C Cowie; M Rowland; D D Byrd-Holt
Journal:  Diabetes Care       Date:  1998-08       Impact factor: 19.112

7.  Waits to see an emergency department physician: U.S. trends and predictors, 1997-2004.

Authors:  Andrew P Wilper; Steffie Woolhandler; Karen E Lasser; Danny McCormick; Sarah L Cutrona; David H Bor; David U Himmelstein
Journal:  Health Aff (Millwood)       Date:  2008-01-15       Impact factor: 6.301

8.  A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol.

Authors:  Roy W Beck; Pamela S Moke; Andrew H Turpin; Frederick L Ferris; John Paul SanGiovanni; Chris A Johnson; Eileen E Birch; Danielle L Chandler; Terry A Cox; R Clifford Blair; Raymond T Kraker
Journal:  Am J Ophthalmol       Date:  2003-02       Impact factor: 5.258

9.  [Patient Mobility and Journey Distance as Risk Factors for Severe Visual Impairment: Real-Life Data Analysis of Treatment-naïve Patients with nAMD under Intravitreal Aflibercept Therapy].

Authors:  Teresa Rauchegger; Reinhard Angermann; Anja Meusburger; Jana Schwab; Gertrud Haas; Martina Kralinger; Claus Zehetner
Journal:  Klin Monbl Augenheilkd       Date:  2019-11-26       Impact factor: 0.700

Review 10.  Barriers and Facilitators to Healthy Lifestyle Changes in Minority Ethnic Populations in the UK: a Narrative Review.

Authors:  Naina Patel; Harriet Batista Ferrer; Freya Tyrer; Paula Wray; Azhar Farooqi; Melanie J Davies; Kamlesh Khunti
Journal:  J Racial Ethn Health Disparities       Date:  2016-12-07
View more
  1 in total

1.  Revisiting NICE guidelines for initiation of intravitreal anti-VEGF therapy for centre-involving diabetic macular oedema: a survey of current interpretation in the United Kingdom.

Authors:  Christiana Dinah; Sam Myers; Sreekumari Pushpoth; Simona Degli-Esposti
Journal:  Eye (Lond)       Date:  2022-01-25       Impact factor: 4.456

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.